Multidimensional molecular mechanisms of drug resistance in breast cancer: Implications for clinical decision-making and treatment strategies (Review)

Wenya Xu, Shiyao Kang, Shaochen Xin, Yanbin Wu, Yuan Zhao, Miaomiao Sheng · 2026

Read Multidimensional molecular mechanisms of drug resistance in breast cancer: Implications for clinical decision-making and treatment strategies (Review) by Wenya Xu, Shiyao Kang, Shaochen Xin, Yanbin Wu, Yuan Zhao, Miaomiao Sheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13443289.txt.

Description

Wenya Xu and colleagues review how breast cancer learns to resist drugs in a 2026 paper. Care spans hormone, chemo, and targeted drugs, yet gained resistance still caps how long each works. The review sorts resistance into five core routes that tumors mix and match.

Pump proteins flush drugs out of cells as route one. Low-air, immune-quiet niches and stem-like cells form route two. Gene-silencing marks and small RNAs rewire cell rules as route three, while spare DNA repair paths blunt chemo as route four. Fuel rewiring feeds growth and dodges immunity as route five. For each route the authors list matched counter-moves, from paired targeted drugs to immune adds. They stress that mixed routes demand mixed plans.

Catalog record

CREATORWenya Xu, Shiyao Kang, Shaochen Xin, Yanbin Wu, Yuan Zhao, Miaomiao Sheng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13443289

Browse the full library · About the Tower of Babel